Are topical oestrogens useful in faecal incontinence? Double-blind randomized trial

Colorectal Disease

Volumn 11, Issue 4, 2009, Pages 390-393

  Pinedo, G ^a   Garcia E ^a   Zarate A J ^a   Leon F ^a   Bellolio, F ^a   Molina, M E ^a   Viviani, P ^a   Zuniga A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Faecal incontinence; Randomized trial; Topical oestrogen

Indexed keywords

ESTRIOL; PLACEBO;

ADULT; AGED; ANUS CONTINENCE; ANUS PRURITUS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; FECES INCONTINENCE; FEMALE; HUMAN; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECTUM MUCOSA; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; CLOPROSTENOL; DOUBLE-BLIND METHOD; ESTRIOL; FECAL INCONTINENCE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 65249088525     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01624.x     Document Type: Article

References (17)

1. Perry S, Shaw C, McGrother C et.al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 2002; 50: 480-4.
2. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: A population-based study. J Gerontol A Biol Sci Med Sci 1995; 50: 184-9.
3. Edwards NI, Jones D. The prevalence of faecal incontinence in older people living at home. Age Ageing 2001; 30: 503-7.
4. Sultan AH, Kamm MA, Hudson CN, Thomas JM, Bartram CI. Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993; 329: 1905-11.
5. Fynes M, Donnelly V, Behan M, O'Connell PR, O'Herlihy C. Effect of second vaginal delivery on anorectal physiology and faecal continence: A prospective study. Lancet 1999; 354: 983-6.
6. Donnelly V, O'Connell PR, O'Herlihy C. The influence of oestrogen replacement on faecal incontinence in postmenopausal women. Br J Obstet Gynaecol 1997; 104: 311-5.
7. Oettling G, Franz HB. Mapping of androgen, estrogen and progesterone receptors in the anal continence organ. Eur J Obstet Gynecol Reprod Biol 1998; 77: 211-6.
8. Rigg LA, Hermann H, Yen SS. Absorption of estrogens from vaginal creams. N Engl J Med 1978; 298: 195-7.
9. Martin PL, Yen SS, Burnier AM, Hermann H. Systemic absorption and sustained effects of vaginal estrogen creams. JAMA 1979; 242: 2699-700.
10. Jorge JM, Wexner SD. Etiology and management of faecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
11. Minguez M, Garrigues V, Soria MJ, Andreu M, Mearin F, Clave P. Adaptation to Spanish language and validation of the faecal incontinence quality of life scale. Dis Colon Rectum 2006; 49: 490-9.
12. Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, Wexner SD, Bliss D, Lowry AC. Faecal Incontinence Quality of Life Scale: quality of life instrument for patients with faecal incontinence. Dis Colon Rectum 2000; 43: 9-16.
13. Pinedo G, Vaizey CJ, Nicholls RJ, Roach R, Halligan S, Kamm MA. Results of repeat anal sphincter repair. Br J Surg 1999; 86: 66-9.
14. Vaizey CJ, Norton C, Thornton MJ, Nicholls RJ, Kamm MA. Long-term results of repeat anterior anal sphincter repair. Dis Colon Rectum 2004; 47: 858-63.
15. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
16. MacLennan AH. HRT: A reappraisal of the risks and benefits. Med J Aust 2007; 186: 643-6.
17. Perry S, McGrother CW, Turner K, Leicestershire MRC Incontinence Study Group. An investigation of the relationship between anxiety and depression and urge incontinence in women: Development of a psychological model. Br J Health Psychol 2006; 11: 463-82.